Medline

Medline ROCE

The Return on Capital Employed (ROCE) of Medline (MDLN) as of Oct 20, 2026 is 11.47 %. In the previous year, Return on Capital Employed (ROCE) was 13.47 % — a change of -14.82% (lower).

ROCE

11.47 %

YoY

-14.82%

Last updated:

In 2025, Medline's return on capital employed (ROCE) was 11.47 %, a -14.82% increase from the 13.47 % ROCE in the previous year.

The Medline ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2023
8.51 USD
Jan 1, 2024
13.47 USD
Jan 1, 2025
11.47 USD
The Medline ROCE history
YEARROCEYoY
11.47 %-14.82%
13.47 %+58.31%
8.51 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medline Stock analysis

What does Medline do? Medline Inc generates revenue through its Medline Brand and Supply Chain Solutions segments. The Medline Brand offers approximately 335,000 medical-surgical products organized into Front Line Care, Surgical Solutions, and Laboratory and Diagnostics categories, serving hospitals, surgery centers, physician offices, and post-acute facilities. Supply Chain Solutions procures and distributes third-party products from national brands while providing tailored logistics and supply chain optimization services to domestic and international customers. The company's mission-critical products include surgical and procedural kits, gloves, protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Medline Brand products target healthcare facilities requiring daily mission-critical supplies, with Front Line Care focusing on immediate patient care needs, Surgical Solutions supporting operating rooms, and Laboratory and Diagnostics serving clinical testing environments. Supply Chain Solutions serves as a distribution partner for national brands, offering logistics expertise to optimize supply chains for healthcare providers across various care settings. The company's product portfolio supports all points of care, from acute to post-acute facilities, ensuring consistent product availability for daily operations. Customers purchasing Medline Brand products include hospitals, surgery centers, physician offices, and post-acute facilities, while Supply Chain Solutions serves domestic and international clients needing third-party product distribution and supply chain services. The firm's offerings cover the full range of care settings, with Surgical Solutions specifically targeting operating room environments and Laboratory and Diagnostics supporting clinical laboratories. Medline's product range ensures healthcare providers have access to essential supplies without disruption in daily operations. Medline is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Medline's Return on Capital Employed (ROCE)

Medline's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Medline's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Medline's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Medline’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Medline stock

Return on Capital Employed (ROCE) of Medline is 11.47 % in 2025.

Return on Capital Employed (ROCE) of Medline changed from 13.47 % to 11.47 %, representing a -14.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Medline since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Medline with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Medline

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Medline